Evolus, Inc. (NASDAQ:EOLS) Q2 2024 Earnings Conference Call July 31, 2024 4:30 PM ET
Company Participants
Nareg Sagherian - Vice President and Head of Global Investor Relations and Corporate Communications
David Moatazedi - President and CEO
Sandra Beaver - CFO
Rui Avelar - Chief Medical Officer and Head of R&D
Conference Call Participants
Jack Padovano - Stifel
Navann Ty - BNP
Serge Belanger - Needham & Company
Operator
Good afternoon, everyone and thank you for standing by. Welcome to Evolus' Second Quarter 2024 Earnings Conference Call. As a reminder, today's conference is being recorded and webcast live. All participants are on a listen-only mode. After the speakers' remarks, there will be a question-and-answer session. I would now like to turn the conference over to your host, Nareg Sagherian, Vice President and Head of Global Investor Relations and Corporate Communications. Please go ahead.
Nareg Sagherian
Thank you, operator, and welcome to everyone joining us on today's call to review Evolus' second quarter 2024 financial results. Our second quarter 2024 press release is now on our website at evolus.com. With me today are David Moatazedi, President and Chief Executive Officer and Sandra Beaver, Chief Financial Officer, Rui Avelar, Chief Medical Officer and Head of R&D is also with us for the Q&A portion of the call.
Before we begin our discussion, I'd like to note that during our call, our prepared remarks will include forward-looking statements within the meaning of United States Securities Laws and management may make additional forward-looking statements in response to your questions. Forward-looking statements are based on management's current assumptions and expectations of future events and trends, which may affect the company's business, strategy, operations or financial performance.
Listeners are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this call and the company undertakes no obligation to update or review any estimates, projections or forward-looking statements except as required by law. These forward-looking statements are based on estimates and assumptions that although believed to be reasonable are inherently uncertain and subject to a number of risks and uncertainties.
A detailed discussion of the risks and uncertainties that the company faces is contained in its annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. Additionally, today's discussion will include non-GAAP financial measures, which should be considered in addition to and not as a substitute for or in isolation from our GAAP results. A reconciliation of GAAP to non-GAAP results maybe found in our earnings release, which was furnished with our Form 8-K filed today with the SEC and on our Investor Relations website at evolus.com. Following the conclusion of today's call, a replay will be available on our website at evolus.com.